Physical Exam Indicated Cerclage in Singleton Gestation 24 Weeks to 25 Weeks and 6 Days Gestation
Randomized Controlled Trial: Physical Exam Indicated Cerclage in Singleton Gestation 24 Weeks to 25 Weeks and 6 Days Gestation
1 other identifier
interventional
30
1 country
1
Brief Summary
RCT assessing preterm delivery rate in singleton pregnancies having a physical-exam indicated cerclage placed between 24 weeks and 25 weeks and 6 days. Patients randomized to either cerclage intervention or routine standard of care (no cerclage).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2022
CompletedStudy Start
First participant enrolled
August 11, 2022
CompletedFirst Posted
Study publicly available on registry
August 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2023
CompletedAugust 16, 2022
August 1, 2022
1 year
August 11, 2022
August 12, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Preterm Delivery Rate
Compare preterm delivery rate between women receiving cerclage intervention between 24w0d and 25w6d vs those not receiving cerclage during this gestational age period
1 Year
Secondary Outcomes (1)
Neonatal Outcomes
1 Year
Other Outcomes (1)
Cerclage Surgical Complications
1 year
Study Arms (2)
Cerclage
EXPERIMENTALPerform physical exam indicated cerclage between 24w0d to 25w6d
Control
NO INTERVENTIONNo intervention; routine monitoring in pregnancy for preterm delivery
Interventions
Eligibility Criteria
You may qualify if:
- Pregnant women 18 years of age or older
- Nulliparous patient, has not had a preterm to term delivery
- Singleton pregnancy
- English or Spanish speaking
- Asymptomatic cervical dilation between 1- 2 cm, without visible membranes beyond the external cervical os and without any evidence of infection, active labor or active bleeding between 24 0/7 and 25 6/7 weeks gestation
You may not qualify if:
- Twin or higher order multi-fetal gestation
- Multiparous patient, has had one or more preterm to term deliveries
- Cervical dilation more than 2 cm either at the beginning of the study or any time during the study
- Amniotic membranes prolapsed beyond the external os
- Fetal reduction procedure performed during current pregnancy
- Ruptured membranes prior to randomization
- Major fetal structural anomaly
- Fetal chromosomal abnormality, suspected or confirmed with additional genetic testing
- Cerclage already in place for other indication
- Active vaginal bleeding
- Suspicion of chorioamnionitis
- Placenta previa
- Painful regular uterine contractions
- History of preterm birth before 37 weeks gestation
- Non-English or non-Spanish speaking
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Albany Medical Center
Albany, New York, 12208, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Maternal Fetal Medicine; MFM Fellowship Director
Study Record Dates
First Submitted
August 11, 2022
First Posted
August 16, 2022
Study Start
August 11, 2022
Primary Completion
August 11, 2023
Study Completion
August 11, 2023
Last Updated
August 16, 2022
Record last verified: 2022-08